doi:10.48130/vns-0026-0013

[1]

Scott IU, Campochiaro PA, Newman NJ, Biousse V. 2020. Retinal vascular occlusions. The Lancet 396(10266):1927−1940

[2]

Campochiaro PA, Bhisitkul RB, Shapiro H, Rubio RG. 2013. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology 120(4):795−802

doi: 10.1016/j.ophtha.2012.09.032

[3]

Nicholson L, Vazquez-Alfageme C, Patrao NV, Triantafyllopolou I, Bainbridge JW, et al. 2017. Retinal nonperfusion in the posterior pole is associated with increased risk of neovascularization in central retinal vein occlusion. American Journal of Ophthalmology 182:118−125

doi: 10.1016/j.ajo.2017.07.015

[4]

Hayreh SS. 2021. Photocoagulation for retinal vein occlusion. Progress in Retinal and Eye Research 85:100964

doi: 10.1016/j.preteyeres.2021.100964

[5]

Fuma S, Nishinaka A, Inoue Y, Tsuruma K, Shimazawa M, et al. 2017. A pharmacological approach in newly established retinal vein occlusion model. Scientific Reports 7:43509

doi: 10.1038/srep43509

[6]

Battaglia Parodi M, Arrigo A, Antropoli A, Bianco L, Saladino A, et al. 2023. Deep capillary plexus as biomarker of peripheral capillary nonperfusion in central retinal vein occlusion. Ophthalmology Science 3(2):100267

doi: 10.1016/j.xops.2022.100267

[7]

Tan TE, Ibrahim F, Chandrasekaran PR, Teo KYC. 2023. Clinical utility of ultra-widefield fluorescein angiography and optical coherence tomography angiography for retinal vein occlusions. Frontiers in Medicine 10:1110166

doi: 10.3389/fmed.2023.1110166

[8]

de Carlo TE, Romano A, Waheed NK, Duker JS. 2015. A review of optical coherence tomography angiography (OCTA). International Journal of Retina and Vitreous 1:5

doi: 10.1186/s40942-015-0005-8

[9]

Spaide RF, Fujimoto JG, Waheed NK. 2015. Optical coherence tomography angiography. Retina 35:2161−2162

doi: 10.1097/iae.0000000000000881

[10]

Seknazi D, Coscas F, Sellam A, Rouimi F, Coscas G, et al. 2018. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL VEIN OCCLUSION: correlations between macular vascular density, visual acuity, and peripheral nonperfusion area on fluorescein angiography. Retina 38(8):1562−1570

doi: 10.1097/IAE.0000000000001737

[11]

Zhu ZY, Meng YA, Yan B, Luo J. 2021. Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy. International Journal of Ophthalmology 14(11):1647−1652

doi: 10.18240/ijo.2021.11.01

[12]

Bruera MG, Benedetto MM, Guido ME, Degano AL, Contin MA. 2022. Glial cell response to constant low light exposure in rat retina. Visual Neuroscience 39:E005

doi: 10.1017/S0952523822000049

[13]

Carrera-Escalé L, Benali A, Rathert AC, Martín-Pinardel R, Bernal-Morales C, et al. 2023. Radiomics-based assessment of OCT angiography images for diabetic retinopathy diagnosis. Ophthalmology Science 3(2):100259

doi: 10.1016/j.xops.2022.100259

[14]

Meng Z, Chen Y, Li H, Zhang Y, Yao X, et al. 2024. Machine learning and optical coherence tomography-derived radiomics analysis to predict persistent diabetic macular edema in patients undergoing anti-VEGF intravitreal therapy. Journal of Translational Medicine 22(1):358

doi: 10.1186/s12967-024-05141-7

[15]

Zheng F, Deng X, Zhang Q, He J, Ye P, et al. 2023. Advances in swept-source optical coherence tomography and optical coherence tomography angiography. Advances in Ophthalmology Practice and Research 3(2):67−79

doi: 10.1016/j.aopr.2022.10.005

[16]

Laíns I, Wang JC, Cui Y, Katz R, Vingopoulos F, et al. 2021. Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Progress in Retinal and Eye Research 84:100951

doi: 10.1016/j.preteyeres.2021.100951

[17]

Le D, Son T, Yao X. 2021. Machine learning in optical coherence tomography angiography. Experimental Biology and Medicine 246(20):2170−2183

doi: 10.1177/15353702211026581

[18]

Sil Kar S, Sevgi DD, Dong V, Srivastava SK, Madabhushi A, et al. 2021. Multi-compartment spatially-derived radiomics from optical coherence tomography predict anti-VEGF treatment durability in macular edema secondary to retinal vascular disease: preliminary findings. IEEE Journal of Translational Engineering in Health and Medicine 9:1000113

doi: 10.1109/JTEHM.2021.3096378

[19]

McKay KM, Chu Z, Kim JB, Legocki A, Zhou X, et al. 2021. Automated quantification of choriocapillaris lesion area in patients with posterior uveitis. American Journal of Ophthalmology 231:179−193

doi: 10.1016/j.ajo.2021.06.004

[20]

Tamošiūnas M, Čiževskis O, Viškere D, Melderis M, Rubins U, et al. 2022. Multimodal approach of optical coherence tomography and Raman spectroscopy can improve differentiating benign and malignant skin tumors in animal patients. Cancers 14(12):2820

doi: 10.3390/cancers14122820

[21]

Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, et al. 2020. Grad-CAM: visual explanations from deep networks via gradient-based localization. International Journal of Computer Vision 128(2):336−359

doi: 10.1007/s11263-019-01228-7

[22]

Gurudas S, Patrao N, Nicholson L, Sen P, Ramu J, et al. 2022. Visual outcomes associated with patterns of macular edema resolution in central retinal vein occlusion treated with anti-vascular endothelial growth factor therapy: a post hoc analysis of the lucentis, eylea, avastin in vein occlusion (LEAVO) trial. JAMA Ophthalmology 140(2):143−150

doi: 10.1001/jamaophthalmol.2021.5619

[23]

Freund KB, Sarraf D, Leong BCS, Garrity ST, Vupparaboina KK, et al. 2018. Association of optical coherence tomography angiography of collaterals in retinal vein occlusion with major venous outflow through the deep vascular complex. JAMA Ophthalmology 136(11):1262−1270

doi: 10.1001/jamaophthalmol.2018.3586

[24]

Çavdarlı C, Büyükyılmaz G, Çavdarlı B, Çomçalı S, Topçu Yılmaz P, et al. 2024. Comparison of the optical coherence tomography-angiography (OCT-A) vascular measurements between molecularly confirmed MODY and age-matched healthy controls. Acta Diabetologica 61(7):917−924

doi: 10.1007/s00592-024-02273-6

[25]

Terui T, Kondo M, Sugita T, Ito Y, Kondo N, et al. 2011. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion. Retina 31(6):1068−1074

doi: 10.1097/IAE.0b013e31820c83c2

[26]

Cabral D, Coscas F, Glacet-Bernard A, Pereira T, Geraldes C, et al. 2019. Biomarkers of peripheral nonperfusion in retinal venous occlusions using optical coherence tomography angiography. Translational Vision Science & Technology 8(3):7

doi: 10.1167/tvst.8.3.7

[27]

Xu Y, Zhang M, Wang H, Yu S. 2024. Associations between the vessel density in deep vascular plexus and macular edema recurrences in patients with retinal vein occlusion. Ophthalmic Research 67(1):584−593

doi: 10.1159/000541531

[28]

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, et al. 2017. Computational radiomics system to decode the radiographic phenotype. Cancer Research 77(21):e104−e107

doi: 10.1158/0008-5472.CAN-17-0339

[29]

Peng H, Long F, Ding C. 2005. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Transactions on Pattern Analysis and Machine Intelligence 27(8):1226−1238

doi: 10.1109/TPAMI.2005.159

[30]

Liu Z, Mao H, Wu CY, Feichtenhofer C, Darrell T, et al. 2022. A ConvNet for the 2020s. 2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 18–24 June 2022, New Orleans, LA, USA. USA: IEEE. pp. 11966–11976 doi: 10.1109/CVPR52688.2022.01167

[31]

Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, et al. 2017. Attention is all you need. 31^st International Conference on Neural Information Processing Systems (NIPS), Long Beach, CA, USA. Red Hook, NY: Curran Associates Inc. pp. 5998–6008. https://proceedings.neurips.cc/paper/2017/hash/3f5ee243547dee91fbd053c1c4a845aa-Abstract.html

[32]

Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, et al. 2014. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121(1):209−219

doi: 10.1016/j.ophtha.2013.08.038

[33]

Abri Aghdam K, Reznicek L, Soltan Sanjari M, Klingenstein A, Kernt M, et al. 2017. Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion. Clinical Ophthalmology 11:331−336

doi: 10.2147/OPTH.S125486

[34]

Mir TA, Kherani S, Hafiz G, Scott AW, Zimmer-Galler I, et al. 2016. Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion. Ophthalmology 123(3):625−634.e1

doi: 10.1016/j.ophtha.2015.10.030

[35]

An W, Zhao Q, Yu R, Han J. 2022. The role of optical coherence tomography angiography in distinguishing ischemic versus non-ischemic central retinal vein occlusion. BMC Ophthalmology 22(1):413

doi: 10.1186/s12886-022-02637-y

[36]

Duan J, Li M, Wu Z, Zhang Z. 2021. Total venous nature of retinal deep capillary plexus inferred by continuity of prominent middle limiting membrane sign in optical coherence tomography. PLoS One 16(9):e0257698

doi: 10.1371/journal.pone.0257698

[37]

Luo W, Li Y, Urtasun R, Zemel R. 2017. Understanding the effective receptive field in deep convolutional neural networks. arXiv 1701.04128v2

doi: 10.48550/arXiv.1701.04128

[38]

Ding X, Zhang X, Han J, Ding G. 2022. Scaling up your kernels to 31x31: revisiting large kernel design in cnns. 2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 18–24 June 2022, New Orleans, LA, USA. USA: IEEE. pp. 11953–11965 doi: 10.1109/CVPR52688.2022.01166

[39]

Chhabria S, Khedkar S, Dongre P, Jangde S, Rangari S, et al. 2024. OCT vision: retinal disease detection using deep learning. 2024 International Conference on Artificial Intelligence and Quantum Computation-Based Sensor Application (ICAIQSA), 20–21 December 2024, Nagpur, India. USA: IEEE. pp. 1–6 doi: 10.1109/icaiqsa64000.2024.10882359

[40]

Choi EY, Kim D, Kim J, Kim E, Lee H, et al. 2025. Predicting branch retinal vein occlusion development using multimodal deep learning and pre-onset fundus hemisection images. Scientific Reports 15(1):2729

doi: 10.1038/s41598-025-85777-7

[41]

Trouilloud A, Ferry E, Boucart M, Kauffmann L, Warniez A, et al. 2023. Impact of glaucoma on the spatial frequency processing of scenes in central vision. Visual Neuroscience 40:E001

doi: 10.1017/S0952523822000086

[42]

Tsay K, Safari S, Abou-Samra A, Kremers J, Tzekov R. 2023. Pre-stimulus bioelectrical activity in light-adapted ERG under blue versus white background. Visual Neuroscience 40:E004

doi: 10.1017/S0952523823000032

[43]

O'Hare L, Hibbard PB. 2024. Support for the efficient coding account of visual discomfort. Visual Neuroscience 41:E008

doi: 10.1017/S0952523824000051

[44]

Kremers J, Huchzermeyer C. 2024. Electroretinographic responses to periodic stimuli in primates and the relevance for visual perception and for clinical studies. Visual Neuroscience 41:E004

doi: 10.1017/S0952523824000038

[45]

Scott MTW, Yakovleva A, Norcia AM. 2024. Visual field asymmetries in responses to ON and OFF pathway biasing stimuli. Visual Neuroscience 41:E007

doi: 10.1017/S095252382400004X

[46]

Dering B, Wright D, Gheorghiu E. 2024. The interaction between luminance polarity grouping and symmetry axes on the ERP responses to symmetry. Visual Neuroscience 41:E005

doi: 10.1017/S0952523824000075

[47]

Arthur C, Kavcar OB, Wise MV, Crognale MA. 2024. Pattern reversal chromatic VEPs like onsets, are unaffected by attentional demand. Visual Neuroscience 41:E006

doi: 10.1017/S0952523824000063